{"author": null, "casenumber": "CA 9/2000", "casename": "Merck & Co, Inc v Pharmaforte Singapore Pte Ltd", "citation": "[2000] SGCA 39", "coram": "Chao Hick Tin JA; L P Thean JA; Yong Pung How CJ", "counsel": "P Sivakumar and Vicki Heng (Ella Cheong & G Mirandah) for the appellants; Ranvir Kumar Singh and Vivienne Kaur (Kumar & Loh) for the respondents", "headings": [], "decorations": [], "tags": ["Patents and Inventions/Novelty", "Patents and Inventions/Infringement", "Patents and Inventions/Inventive step"], "tags-parsed": ["Patents and Inventions/Infringement/Validity of patent", "Patents and Inventions/Novelty/Lack of utility in invention/Registered patent comprising Lovastatin/Allegation that Apo-Lovastatin infringes patent comprising Lovastatin/Definition of \"utility\"/Whether lack of utility renders invention unpatentable for want of novelty/Whether differences in degree of compound patentable/Whether invention anticipated by prior art", "Patents and Inventions/Inventive step/Whether invention obvious to person skilled in the art/Whether mere discovery patentable/Whether person skilled in the art could use existing standard techniques to purify Lovastatin"]}